Back to search

Io Biotech Limited

13553522

active
Private Limited Company
Companies House
Health Score
75 / 100

Some Concerns

25/30
Filing
10/30
Financial
40/40
Risk
  • No accounts filed in last 18 months (-5)
  • Current liabilities exceed current assets (-10)

Details

MERLIN HOUSE PRIORY DRIVE, NEWPORT, NP18 2HJ
Incorporated 06/08/2021

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology
72190
Other research and experimental development on natural sciences and engineering

Officers

Dr. Mai-Britt Zocca

director · Since 11/04/2025

FOUNDER AND CEO

DANISH · DENMARK · Age 58

Persons with Significant Control

Io Biotech Aps

75–100% shares

C/O Cobis, Ole Maaloes Vej 3, Copenhagen

Reg: 36474483 · Danish Business Authority Central Business Register · Limited Liability Company

Notified 06/08/2021

CompanyRankvs 420+ SIC 72110 peers
75

Financial strength83th percentile among SIC peers · 21/25
Employees95th percentile among SIC peers · 14/15
LiquidityCurrent ratio 4× · 20/20
Longevity5 years trading (max 15) · 5/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength21/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity5/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 30/06/2024

Net Worth

£185k

Balance sheet strength

Cash

£247k

Cash in the bank

Net Current Assets

£185k

Working capital

Current Assets

£247k

Current Liabilities

£62k

15avg. employees+3

Balance Sheet

Assets less current liabilities£185k
Signed by Mr Christian Knappe 13/02/2025Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20244.00+£50k
20231.32+£76k
20221.06

Derived from filed accounts. Not audited figures.